Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Association of socioeconomic status with mortality in type 1 diabetes: the Pittsburgh epidemiology of diabetes complications study.

Secrest AM, Costacou T, Gutelius B, Miller RG, Songer TJ, Orchard TJ.

Ann Epidemiol. 2011 May;21(5):367-73. doi: 10.1016/j.annepidem.2011.02.011.

2.

Associations between socioeconomic status and major complications in type 1 diabetes: the Pittsburgh epidemiology of diabetes complication (EDC) Study.

Secrest AM, Costacou T, Gutelius B, Miller RG, Songer TJ, Orchard TJ.

Ann Epidemiol. 2011 May;21(5):374-81. doi: 10.1016/j.annepidem.2011.02.007.

3.

Association Between Socioeconomic Status and Mortality, Cardiovascular Disease, and Cancer in Patients With Type 2 Diabetes.

Rawshani A, Svensson AM, Zethelius B, Eliasson B, Rosengren A, Gudbjörnsdottir S.

JAMA Intern Med. 2016 Aug 1;176(8):1146-54. doi: 10.1001/jamainternmed.2016.2940.

PMID:
27367969
4.

Impact of parental socioeconomic status on excess mortality in a population-based cohort of subjects with childhood-onset type 1 diabetes.

Berhan YT, Eliasson M, Möllsten A, Waernbaum I, Dahlquist G; Swedish Childhood Diabetes Study Group 2013.

Diabetes Care. 2015 May;38(5):827-32. doi: 10.2337/dc14-1522. Epub 2015 Feb 20.

PMID:
25710924
5.

Cause-specific mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes.

Secrest AM, Becker DJ, Kelsey SF, Laporte RE, Orchard TJ.

Diabetes. 2010 Dec;59(12):3216-22. doi: 10.2337/db10-0862. Epub 2010 Aug 25.

7.

Impact of Socioeconomic Status on Cardiovascular Disease and Mortality in 24,947 Individuals With Type 1 Diabetes.

Rawshani A, Svensson AM, Rosengren A, Eliasson B, Gudbjörnsdottir S.

Diabetes Care. 2015 Aug;38(8):1518-27. doi: 10.2337/dc15-0145. Epub 2015 May 13.

PMID:
25972573
8.

Comparison of different markers of socioeconomic status with cardiovascular disease and diabetes risk factors in the Diabetes, Heart and Health Survey.

Metcalf PA, Scragg RR, Schaaf D, Dyall L, Black PN, Jackson RT.

N Z Med J. 2008 Feb 15;121(1269):45-56.

PMID:
18278081
9.

Hemoglobin and overt nephropathy complications in type 1 diabetes.

Conway B, Fried L, Orchard T.

Ann Epidemiol. 2008 Feb;18(2):147-55.

10.

Predictors of mortality and end-stage diabetic complications in patients with Type 1 diabetes mellitus on intensified insulin therapy.

Mühlhauser I, Overmann H, Bender R, Jörgens V, Berger M.

Diabet Med. 2000 Oct;17(10):727-34.

PMID:
11110506
11.

Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study.

Orchard TJ, Forrest KY, Kuller LH, Becker DJ; Pittsburgh Epidemiology of Diabetes Complications Study.

Diabetes Care. 2001 Jun;24(6):1053-9.

PMID:
11375370
12.

Socioeconomic status and diagnosed diabetes incidence.

Robbins JM, Vaccarino V, Zhang H, Kasl SV.

Diabetes Res Clin Pract. 2005 Jun;68(3):230-6.

PMID:
15936465
13.

Socioeconomic status and risk of diabetes-related mortality in the U.S.

Saydah S, Lochner K.

Public Health Rep. 2010 May-Jun;125(3):377-88.

14.

Effect of socioeconomic status on mortality after bacteremia in working-age patients. A Danish population-based cohort study.

Koch K, Nørgaard M, Schønheyder HC, Thomsen RW, Søgaard M; Danish Collaborative Bacteremia Network.

PLoS One. 2013 Jul 25;8(7):e70082. doi: 10.1371/journal.pone.0070082. Print 2013.

15.

Is glycaemia or insulin dose the stronger risk factor for coronary artery disease in type 1 diabetes?

Conway B, Costacou T, Orchard T.

Diab Vasc Dis Res. 2009 Oct;6(4):223-30. doi: 10.1177/1479164109336041. Epub 2009 Aug 4.

16.

Dimensions of socioeconomic status and clinical outcome after primary percutaneous coronary intervention.

Jakobsen L, Niemann T, Thorsgaard N, Thuesen L, Lassen JF, Jensen LO, Thayssen P, Ravkilde J, Tilsted HH, Mehnert F, Johnsen SP.

Circ Cardiovasc Interv. 2012 Oct;5(5):641-8. doi: 10.1161/CIRCINTERVENTIONS.112.968271. Epub 2012 Oct 2.

17.

Education, income, occupation, and the 34-year incidence (1965-99) of Type 2 diabetes in the Alameda County Study.

Maty SC, Everson-Rose SA, Haan MN, Raghunathan TE, Kaplan GA.

Int J Epidemiol. 2005 Dec;34(6):1274-81. Epub 2005 Aug 24.

18.

Association between HbA1c and cardiovascular disease mortality in older Hong Kong Chinese with diabetes.

Xu L, Chan WM, Hui YF, Lam TH.

Diabet Med. 2012 Mar;29(3):393-8. doi: 10.1111/j.1464-5491.2011.03456.x.

PMID:
21916977
19.

Association of childhood and adult socioeconomic indicators with cardiovascular risk factors and its modification by age: the CARLA Study 2002-2006.

Schumann B, Kluttig A, Tiller D, Werdan K, Haerting J, Greiser KH.

BMC Public Health. 2011 May 10;11:289. doi: 10.1186/1471-2458-11-289.

20.

C-peptide and the risk for incident complications and mortality in type 2 diabetic patients: a retrospective cohort study after a 14-year follow-up.

Bo S, Gentile L, Castiglione A, Prandi V, Canil S, Ghigo E, Ciccone G.

Eur J Endocrinol. 2012 Aug;167(2):173-80. doi: 10.1530/EJE-12-0085. Epub 2012 May 10.

Supplemental Content

Support Center